Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial
Current Microbiology · 2023
DOI: 10.1007/s00284-023-03444-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Current Microbiology, 2023. Verfasst von Yujiao Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Infants born via cesarean section (CS) are at an increased risk of immune-related diseases later in life, potentially due to altered gut microbiota. Recent research has focused on the administration of probiotics in the prevention of gut microbiota dysbiosis in neonates delivered by CS. This study was performed to investigate the effects of probiotic supplementation on the gut microbiota of CS-delivered infants. METHODS: Thirty full-term neonates delivered by CS were randomized into the intervention (supplemented orally with a probiotic containing Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis for 2 weeks) and control groups. Stool samples were collected at birth and 2 weeks and 42 days after birth. The composition of the gut microbiota was analyzed using 16S rRNA sequencing technology. RESULTS: The applied bacterial strains were abundant in the CS-delivered infants supplemented with probiotics. Probiotics increased the abundance of some beneficial bacteria, such as Bacteroides, Acinetobacter, Veillonella, and Faecalibacterium. Low colonization of Klebsiella, a potentially pathogenic bacterium, was observed in the intervention group. CONCLUSIONS: Our results showed that probiotics supplemented immediately after CS enriched the gut microbiota composition and altered the pattern of early gut colonization. TRIAL REGISTRATION: registration number NCT05086458.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai, China.
- Institute for Intestinal Diseases, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai, China.
- Department of Pediatrics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai, China. yangrongtongji@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gong, Y., Zhong, H., Wang, J., Wang, X., Huang, L., Zou, Y., Qin, H., & Yang, R. (2023). Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. Current Microbiology. https://doi.org/10.1007/s00284-023-03444-4
Vancouver
Gong Y, Zhong H, Wang J, Wang X, Huang L, Zou Y, et al. Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial. Current Microbiology. 2023. doi:10.1007/s00284-023-03444-4
BibTeX
@article{Gong2023,
author = {Gong, Yujiao and Zhong, Hui and Wang, Jing and Wang, Xianggeng and Huang, Linsheng and Zou, Yutong and Qin, HuanLong and Yang, Rong},
title = {Effect of Probiotic Supplementation on the Gut Microbiota Composition of Infants Delivered by Cesarean Section: An Exploratory, Randomized, Open-label, Parallel-controlled Trial},
journal = {Current Microbiology},
year = {2023},
doi = {10.1007/s00284-023-03444-4}
}
EUVIMED